Login / Signup

The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study.

Jamy D ArdIan J NeelandAmy E RothbergRobert J ChiltonDaniel de LuisSarah S CohenOdd Erik Johansen
Published in: Diabetes, obesity & metabolism (2023)
In people with obesity at low ASCVD risk, OP significantly reduced cardiovascular risk factors and 10-year predicted risk for ASCVD.
Keyphrases
  • cardiovascular risk factors
  • metabolic syndrome
  • insulin resistance
  • type diabetes
  • weight loss
  • cardiovascular disease
  • study protocol
  • body mass index